Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Aethlon Medical filings provide 15 years of Shares Outstanding (Weighted Average) readings, the most recent being $235711.0 for Q1 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 24.96% to $235711.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $235711.0, a 24.96% decrease, with the full-year FY2025 number at $235711.0, down 24.96% from a year prior.
  • Shares Outstanding (Weighted Average) hit $235711.0 in Q1 2025 for Aethlon Medical, up from $147520.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.5 million in Q2 2022 to a low of $4090.0 in Q1 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $2.3 million (2022), compared with a mean of $5.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 97.1% in 2022 and later surged 7579.63% in 2024.
  • Aethlon Medical's Shares Outstanding (Weighted Average) stood at $14.5 million in 2021, then crashed by 84.22% to $2.3 million in 2022, then grew by 9.67% to $2.5 million in 2023, then plummeted by 94.14% to $147520.0 in 2024, then skyrocketed by 59.78% to $235711.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $235711.0 (Q1 2025), $147520.0 (Q4 2024), and $13.4 million (Q3 2024) per Business Quant data.